Rachman Ilya M

Rachman Ilya M, CEO and Chairman, Director, accounts for 3 disclosed filings worth $4.4M, all concentrated in Immix Biopharma, Inc. (IMMX), active 2025–2026. The record is heavily weighted toward buying, with $10.0K in purchases against $0 in sales. The largest single open-market purchase on record is $5.0K in Immix Biopharma, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.